Form EFFECT - Notice of Effectiveness

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Form EFFECT - Notice of Effectiveness

Dynex Capital (NYSE:DX-C)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Dynex Capital Charts.

Dynex Capital (NYSE:DX-C)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Dynex Capital Charts.

Dynex Capital Inc News

Form 8-K - Current report
Thursday 19 December 2024 (3 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 29 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Tuesday 29 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 28 October 2024 (2 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Sunday 27 October 2024 (2 months ago) • Edgar (US Regulatory)

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
Tuesday 22 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 21 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 10 September 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 10 September 2024 (3 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 29 August 2024 (4 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 29 August 2024 (4 months ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Thursday 1 August 2024 (5 months ago) • Edgar (US Regulatory)

More Dynex Capital Inc News Articles

Asia Broadband (PK)

Anavex Life Sciences

Lightwave Logic

Digital Brand Media and ... (PK)

Elite Pharmaceuticals (QB)

Fannie Mae (QB)

Kraig Biocraft Laborator... (QB)

Northwest Biotherapeutics (QB)

Rennova Health (CE)

Tonix Pharmaceuticals

Code Green Apparel (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions